Intrauterine transfusion

Intrauterine transfusion (IUT) is a medical procedure used to treat fetal anemia and other conditions where the fetus requires blood. This procedure is typically performed when the fetus is at risk due to conditions such as Rh disease, also known as hemolytic disease of the fetus and newborn (HDFN), or infections that can lead to fetal anemia. Intrauterine transfusion is a critical intervention that can significantly improve fetal outcomes and survival rates.

Indications

The primary indication for intrauterine transfusion is significant fetal anemia. This can be due to several causes, including:

• Rh disease: A condition where the blood types of the mother and fetus are incompatible, leading to the mother's immune system attacking the fetal red blood cells.
• Parvovirus B19 infection: A viral infection that can suppress the production of red blood cells in the fetus.
• Alpha-thalassemia: A genetic disorder affecting hemoglobin production, leading to anemia in the fetus.

Procedure

The intrauterine transfusion procedure is performed under ultrasound guidance to ensure accuracy and safety. It involves two main approaches:

• Percutaneous umbilical blood sampling (PUBS): Also known as cordocentesis, this involves the direct transfusion of blood into the umbilical vein.
• Intraperitoneal transfusion: This involves injecting the blood into the fetal peritoneal cavity, from where the blood cells are absorbed into the fetal circulation.

The choice between these methods depends on the gestational age, the condition being treated, and the expertise of the medical team.

Risks and Complications

While intrauterine transfusion is a life-saving procedure, it carries risks and potential complications, including:

• Premature labor
• Fetal bradycardia (slow heart rate)
• Hemorrhage
• Infection
• Fetal death

The procedure requires a high level of skill and experience, and is usually performed in specialized centers.

Outcomes

The success of intrauterine transfusion has significantly improved the prognosis for fetuses with severe anemia. With timely and repeated interventions, many affected fetuses can survive and have healthy outcomes. However, the long-term prognosis depends on the underlying cause of the anemia and the presence of any other complications.

Future Directions

Advancements in fetal medicine and genetic testing continue to improve the diagnosis and treatment of fetal conditions that may require intrauterine transfusion. Research into alternative treatments and preventive measures is ongoing, with the aim of reducing the need for invasive procedures.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian